Tocilizumab Provides Dual Benefits in Treating Immune Checkpoint Inhibitor-Associated Arthritis and Preventing Relapse During ICI Rechallenge: the TAPIR Study
ANNALS OF ONCOLOGY（2025）
Key words
immune checkpoint inhibitors,irAEs,arthritis,secondary prophylaxis,tocilizumab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined